12th Tumor Models Boston
Evvnt Promotion / evvnt
Archive
23.07.2024 - 24.07.2024 The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, Massachusetts, USA
Time: 8:00 AM - 4:10 PM
Conference themes
In the wake of the FDA Modernization Act and translational rates of cancer drugs into the clinic at just 20%, it is critical that oncology scientists invest in more translational and predictive models to de-risk the validation of novel targets, predict therapeutic response, and support biomarker discovery.
In the wake of the FDA Modernization Act and translational rates of cancer drugs into the clinic at just 20%, it is critical that oncology scientists invest in more translational and predictive models to de-risk the validation of novel targets, predict therapeutic response, and support biomarker discovery.
Professional congress organizer (PCO)
Hanson Wade Group
Hanson Wade Group
Notes
Brochure: https://go.evvnt.com/2397551-3?pid=4832
Speakers: Alexander Adler, Principal Scientist and Research Associate, Regeneron Pharmaceuticals Inc, Alina Ainbinder, Principal Scientist, Takeda Pharmaceuticals Co. Ltd., and more
Brochure: https://go.evvnt.com/2397551-3?pid=4832
Speakers: Alexander Adler, Principal Scientist and Research Associate, Regeneron Pharmaceuticals Inc, Alina Ainbinder, Principal Scientist, Takeda Pharmaceuticals Co. Ltd., and more
Enquiries and Registration:
https://go.evvnt.com/2397551-2?pid=4832
Mr. Alex Domingo
Oncology
Languages
English
English
Congress fees
Drug Developer, Researchers and Academic - 2 Day Conference Pass: USD 0.50, Solution Provider - 2 Day Conference Pass: USD 3699.00
Drug Developer, Researchers and Academic - 2 Day Conference Pass: USD 0.50, Solution Provider - 2 Day Conference Pass: USD 3699.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
